Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Thomas, Lad"'
Autor:
Christina Nowicki, Lucille Ray, Philip Engen, Andrea Madrigrano, Thomas Witt, Thomas Lad, Melody Cobleigh, Ece A. Mutlu
Publikováno v:
Frontiers in Microbiology, Vol 14 (2023)
AimThe goal of this study is to compare microbiome composition in three different sample types in women, namely stool brought from home vs. solid stool samples obtained at the time of an unprepped sigmoidoscopy vs. biopsies of the colonic mucosa at t
Externí odkaz:
https://doaj.org/article/91af0492839345e4b7076c169e1569a8
Publikováno v:
Cancer Control, Vol 28 (2021)
We tested whether a low-literacy-friendly, multimedia information and assessment system used in daily clinical practice enhanced patient-centered care and improved patient outcomes. This was a prospective, parallel-group, randomized controlled trial
Externí odkaz:
https://doaj.org/article/69cf9752f85744c1a06ca1b5ab236666
Autor:
Blanca Noriega Esqu, Sara St. George, Patricia Moreno, Tae Lee, Edgar Munoz, Thomas Lad, Allan Pollack, Courtney Hollowell, Amelie Ramirez, Frank Penedo
Purpose We aimed to identify subgroups of Hispanic/Latino (H/L) cancer survivors with distinct health behavior patterns and their associated sociodemographic, medical, and psychosocial characteristics. Methods Baseline data was used from a randomized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9cca2ac96fbfb731a9f42e51cb62497
https://doi.org/10.21203/rs.3.rs-2066115/v1
https://doi.org/10.21203/rs.3.rs-2066115/v1
Autor:
Blanca S, Noriega Esquives, Sara M, St George, Patricia I, Moreno, Tae Kyoung, Lee, Edgar, Munoz, Thomas, Lad, Alan, Pollack, Courtney M P, Hollowell, Amelie G, Ramirez, Frank J, Penedo
Publikováno v:
Journal of cancer survivorship : research and practice.
We aimed to identify subgroups of Hispanic/Latino (H/L) cancer survivors with distinct health behavior patterns and their associated sociodemographic, medical, and psychosocial characteristics.Baseline data were used from a randomized clinical trial
Publikováno v:
Rare Tumors, Vol 8, Iss 3 (2016)
Erlotinib is one of the most widely used tyrosine kinase inhibitor targeting human epidermal growth factor receptor. Since its introduction, it has revolutionized the treatment of advanced non-small cell lung cancer. Skin rashes and diarrhea are the
Externí odkaz:
https://doaj.org/article/c34243b30c5a4f9bb35891e712837d25
Autor:
Sarah, Burdett, Jean Pierre, Pignon, Jayne, Tierney, Helene, Tribodet, Lesley, Stewart, Cecile, Le Pechoux, Anne, Aupérin, Thierry, Le Chevalier, Richard J, Stephens, Rodrigo, Arriagada, Julian P T, Higgins, David H, Johnson, Jan, Van Meerbeeck, Mahesh K B, Parmar, Robert L, Souhami, Bengt, Bergman, Jean-Yves, Douillard, Ariane, Dunant, Chiaki, Endo, David, Girling, Harubumi, Kato, Steven M, Keller, Hideki, Kimura, Aija, Knuuttila, Ken, Kodama, Ritsuko, Komaki, Mark G, Kris, Thomas, Lad, Tommaso, Mineo, Steven, Piantadosi, Rafael, Rosell, Giorgio, Scagliotti, Lesley K, Seymour, Frances A, Shepherd, Richard, Sylvester, Hirohito, Tada, Fumihiro, Tanaka, Valter, Torri, David, Waller, Ying, Liang, V, Torri
Publikováno v:
COCHRANE DATABASE OF SYSTEMATIC REVIEWS
The Cochrane Library
The Cochrane Library
Background To evaluate the effects of administering chemotherapy following surgery, or following surgery plus radiotherapy (known as adjuvant chemotherapy) in patients with early stage non-small cell lung cancer (NSCLC),we performed two systematic re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fad775be360c324a2ef4aa6ba9e3a7f9
https://hdl.handle.net/1854/LU-7072338
https://hdl.handle.net/1854/LU-7072338
Autor:
Ping Zheng, Alexander H.G. Paterson, André Robidoux, Sandra M. Swain, Joseph P. Costantino, Shaker R. Dakhil, Barry C. Lembersky, Thomas Lad, Karen M. King, Adam Brufsky, Stewart J. Anderson, Lorna Weir, Edith A. Perez, Luis Baez-Diaz, Eleftherios P. Mamounas, Carla I. Falkson, Charles E. Geyer, Louis Fehrenbacher, Norman Wolmark, Julie R. Gralow
Publikováno v:
The Lancet. Oncology. 13(7)
Summary Background Bisphosphonates are thought to act through the osteoclast by changing bone microenvironment. Previous findings of adjuvant clodronate trials in different populations with operable breast cancer have been mixed. The National Surgica
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 7:1279